Want to see JP:3544 full AI Analyst Report?
Top Page
SATUDORA HOLDINGS CO., LTD.
(3544)
Select Model
Select Model
Rating:48Neutral
Price Target:
¥1,234.00
▼(-1.20% Downside)
Action:Reiterated
Date:09/25/26
The score is held back primarily by weak financial quality (thin, volatile profitability; high leverage; and reduced/variable free cash flow) and an expensive valuation (P/E ~104 with only ~1% yield). Technicals are comparatively supportive, with price above longer-term moving averages and neutral momentum, but not strong enough to offset the fundamental and valuation risks.
Positive Factors
Steady Revenue Growth
Broadly stable to growing revenue indicates continued demand for the group’s drugstore, health, beauty, and daily-necessity offerings. This provides a durable operating base and supports ongoing store activity, even though the latest growth rate has moderated materially.
Negative Factors
Thin, Declining Profitability
Very low net margins leave limited protection against weaker demand or higher costs, while the sharp decline in net income shows earnings are vulnerable despite stable revenue. This restricts internal reinvestment capacity and makes sustained improvement in operating efficiency important.
Read all positive and negative factors
Positive Factors
Negative Factors
Steady Revenue Growth
Broadly stable to growing revenue indicates continued demand for the group’s drugstore, health, beauty, and daily-necessity offerings. This provides a durable operating base and supports ongoing store activity, even though the latest growth rate has moderated materially.
Read all positive factors
SATUDORA HOLDINGS CO., LTD. (3544) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥17.24B
Dividend Yield0.96%
Average Volume (3M)10.56K
Price to Earnings (P/E)104.3
Beta (1Y)0.03
Revenue Growth-0.23%
EPS Growth-77.29%
CountryJP
Employees1,099
SectorGeneral
Sector StrengthN/A
IndustryMedical - Pharmaceuticals
Share Statistics
EPS (TTM)11.97
Shares Outstanding14,236,564
10 Day Avg. Volume8,050
30 Day Avg. Volume10,556
Financial Highlights & Ratios
PEG Ratio-0.60
Price to Book (P/B)1.12
Price to Sales (P/S)0.11
P/FCF Ratio23.91
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SATUDORA HOLDINGS CO., LTD. Business Overview & Revenue Model
Company Description
Satudora Holdings Co., Ltd. is a Japanese enterprise primarily focused on operating drugstores and dispensing pharmacies. Its business operations are structured into two main divisions: Retail Business and IT Solution Business. Beyond its core ret...
How the Company Makes Money
SATUDORA HOLDINGS primarily makes money through retail sales generated by its drugstore operations. The main revenue stream is product sales to consumers in its stores, typically spanning (where disclosed) pharmaceuticals/OTC medicines, health and...
SATUDORA HOLDINGS CO., LTD. Financial Statement Overview
Summary
Income Statement
48
Neutral
Balance Sheet
42
Neutral
Cash Flow
39
Negative
| Breakdown | TTM | May 2025 | May 2024 | May 2023 | May 2022 | May 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 100.33B | 100.57B | 100.17B | 95.52B | 87.48B | 82.91B |
| Gross Profit | 25.97B | 26.11B | 24.29B | 22.31B | 20.03B | 18.89B |
| EBITDA | 2.74B | 3.00B | 2.80B | 2.36B | 1.58B | 1.73B |
| Net Income | 164.00M | 434.00M | 768.00M | 470.00M | 87.00M | 317.00M |
Balance Sheet | ||||||
| Total Assets | 50.72B | 45.15B | 46.45B | 45.14B | 43.28B | 41.59B |
| Cash, Cash Equivalents and Short-Term Investments | 4.87B | 1.48B | 2.67B | 2.67B | 2.31B | 2.96B |
| Total Debt | 13.29B | 15.23B | 17.21B | 17.39B | 18.11B | 13.88B |
| Total Liabilities | 40.68B | 34.93B | 36.52B | 35.90B | 34.44B | 32.70B |
| Stockholders Equity | 9.94B | 10.11B | 9.80B | 9.13B | 8.73B | 8.80B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 474.00M | 1.32B | 2.10B | -3.81B | -602.00M |
| Operating Cash Flow | 0.00 | 2.32B | 2.60B | 3.54B | -1.77B | 1.28B |
| Investing Cash Flow | 0.00 | -1.14B | -1.67B | -1.92B | -2.87B | -2.23B |
| Financing Cash Flow | 0.00 | -2.37B | -935.00M | -1.26B | 4.00B | 1.27B |
SATUDORA HOLDINGS CO., LTD. Technical Analysis
Positive
1249.00
Price Trends
1248.70
Negative
1112.26
Positive
979.47
Positive
Market Momentum
2.10
Positive
57.68
Neutral
23.81
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3544, the sentiment is Positive. The current price of 1249 is above the 20-day moving average (MA) of 1248.35, above the 50-day MA of 1248.70, and above the 200-day MA of 979.47, indicating a neutral trend. The MACD of 2.10 indicates Positive momentum. The RSI at 57.68 is Neutral, neither overbought nor oversold. The STOCH value of 23.81 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:3544.
SATUDORA HOLDINGS CO., LTD. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | ¥414.61B | 13.20 | 11.15% | 3.69% | 4.32% | 0.18% | |
69 Neutral | ¥488.34B | 15.05 | ― | 1.33% | 8.72% | 3.45% | |
64 Neutral | ¥951.73B | 16.20 | 7.67% | 2.22% | ― | ― | |
62 Neutral | ¥481.13B | 14.61 | 10.75% | 2.00% | 12.20% | -25.42% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ¥356.84B | 20.61 | ― | 0.40% | 13.04% | -0.05% | |
48 Neutral | ¥17.24B | 104.26 | ― | 0.96% | -0.23% | -77.29% |
* General Sector Average
JP:3544
SATUDORA HOLDINGS CO., LTD.
1,248.00
456.67
57.71%
JP:9989
Sundrug Co
3,577.00
-485.22
-11.94%
JP:7649
Sugi Holdings Co
1,253.00
-414.17
-24.84%
JP:3391
TSURUHA Holdings
2,116.00
-157.77
-6.94%
JP:3349
COSMOS Pharmaceutical Corporation
6,153.00
-2,063.34
-25.11%
JP:3549
KUSURI NO AOKI HOLDINGS CO.,LTD.
3,685.00
-44.22
-1.19%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.